| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Investing > Is Real Estate A Good Investment for You? |
|
Top Articles - Is Real Estate A Good Investment for You?
Owning a home is the American Dream, but is buying additional real estate a good investment? It can be so long as According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product you have realistic expectations. There are a lot of investment strategies out there, so why would real estate b ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e on the table? The reason most people invest in real estate is the long term gain. Only in rare cases, such as f lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. lipping a home, will you make a killing in a year. In most cases, you make the big return over a longer period of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe time by paying down the mortgage and watching the home appreciate. Investing in rentals is popular because the re d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nters tend to pay off your mortgage for you. The primary comparable medium for real estate is the stock market. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Many people will argue till their tongues drag that one or the other is better. In truth, they are not that diffe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ent. Over the last 20 years or so, both the stock market and real estate market have returned in the 8 to 12 perc nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ent range. The primary difference between the two, of course, is liquidity. When you want to sell a stock, you ca and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n do so today. The buyer does not need to have the shares inspected to make sure they are in good shape! When co ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sidering investing in real estate, it is important to keep a few guidelines in mind. First, this is a slow and st ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a eady profit strategy. The longer you hang in, the more you will make. Second, there are going to be good years an dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d bad years. Valuations will go up and down, but you should come out ahead in the long run. Third, the cost of in cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin vesting can eat into your profits. Keep in mind the costs of selling such as realtor commissions and transactiona tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen fees. With any investment, it is important to consider the potential risk that everything goes to hell in a han t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d basket. Obviously, this can be a big problem with stocks. A high flying stock today can be a loser in a big way ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust tomorrow. Just ask the folks that owned Enron, Adelphia and so on. The real estate market, on the other hand, te y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ds to be less volatile. Valuations will change from time to time, but drastic moves are rare. The decision to in . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de vest in real estate is one that only you can make. As with most assumptions, real estate may or may not be a good elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip investment strategy for your situation. Make sure to look into the details so you know what you are getting into tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Pros And Cons To Business Incorporation Maryland Real Estate - Coastline Dominates
|